0001773751-24-000002.txt : 20240103
0001773751-24-000002.hdr.sgml : 20240103
20240103164035
ACCESSION NUMBER: 0001773751-24-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231229
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baird Melissa
CENTRAL INDEX KEY: 0001837815
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38986
FILM NUMBER: 24507352
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT STREET, #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hims & Hers Health, Inc.
CENTRAL INDEX KEY: 0001773751
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
BUSINESS PHONE: 415-851-0195
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
FORMER COMPANY:
FORMER CONFORMED NAME: Oaktree Acquisition Corp.
DATE OF NAME CHANGE: 20190412
4
1
wk-form4_1704318023.xml
FORM 4
X0508
4
2023-12-29
0
0001773751
Hims & Hers Health, Inc.
HIMS
0001837815
Baird Melissa
2269 CHESTNUT STREET, #523
SAN FRANCISCO
CA
94123
0
1
0
0
Chief Operating Officer
0
Class A Common Stock
2023-12-29
4
M
0
57339
1.75
A
471804
D
Class A Common Stock
2023-12-29
4
M
0
35661
2.43
A
507465
D
Stock Option (right to buy)
1.75
2023-12-29
4
M
0
57339
0
D
2029-11-06
Class A Common Stock
57339
55906
D
Stock Option (right to buy)
2.43
2023-12-29
4
M
0
35661
0
D
2030-05-13
Class A Common Stock
35661
743412
D
Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 250,000 shares of Hims, Inc., with an exercise price of $0.79. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 113,245 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.
Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. The shares subject to the option will be fully vested on February 12, 2024, subject to the Reporting Person's continuous service. The option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement).
/s/ Carly Larson, Attorney-in-Fact
2024-01-03